Barclays lowered the firm’s price target on CDW (CDW) to $176 from $205 and keeps an Equal Weight rating on the shares post the Q2 report. The firm says the company’s Healthcare and Commercial units offset weakness in Education.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDW: